In primary CDI, fecal microbiota transplantation was noninferior to vancomycin for clinical cure at 14 d without recurrence at 60 d

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine
Published
2025-10-01
DOI
https://doi.org/10.7326/annals-25-03648-jc
Citations
1
Primary Topic
Clostridium difficile and Clostridium perfringens research
Type
article
Field-Weighted Citation Impact
1.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In primary CDI, fecal microbiota transplantation was noninferior to vancomycin for clinical cure at 14 d without recurrence at 60 d

Henry S. Sacks
1 citations
Annals of Internal Medicine
Clostridium difficile and Clostridium perfringens research
1.40
article

In primary CDI, fecal microbiota transplantation was noninferior to vancomycin for clinical cure at 14 d without recurrence at 60 d

Henry S. Sacks
article en
1 citations

Abstract

No abstract available for this paper.
Annals of Internal MedicineVol. 178(10)
Icahn School of Medicine at Mount Sinai (US)
Openalex Percentile: Top 15%
Clostridium difficile and Clostridium perfringens research
1.40
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

In primary CDI, fecal microbiota transplantation was noninferior to vancomycin for clinical cure at 14 d without recurrence at 60 d — Henry S. Sacks · Annals of Internal Medicine (2025) | TGRS Research Map | TGRS